| 发明名称 |
TIE-2 LIGANDE, VERFAHREN ZU IHRER HERSTELLUNG, UND IHRE ANWENDUNGEN |
| 摘要 |
The present invention provides for an isolated nucleic acid molecule encoding a human TIE-2 ligand. In addition, the invention provides for a receptor body which specifically binds a human TIE-2 ligand. The invention also provides an antibody which specifically binds a human TIE-2 ligand. The invention further provides for an antagonist of human TIE-2. The invention also provides for therapeutic compositions as well as a method of blocking blood vessel growth, a method of promoting neovascularization, a method of promoting the growth or differentiation of a cell expressing the TIE-2 receptor, a method of blocking the growth or differentiation of a cell expressing the TIE-2 receptor and a method of attenuating or preventing tumor growth in a human. |
| 申请公布号 |
DE69520149(D1) |
申请公布日期 |
2001.03.29 |
| 申请号 |
DE1995620149 |
申请日期 |
1995.10.06 |
| 申请人 |
REGENERON PHARMACEUTICALS, INC. |
发明人 |
DAVIS, SAMUEL;BRUNO, JOANNE;GOLDFARB, MITCHELL;ALDRICH, H.;MAISONPIERRE, C.;RADZIEJEWSKI, CZESLAW;JONES, F.;YANCOPOULOS, D. |
| 分类号 |
G01N33/50;A61K38/00;A61K38/17;A61K39/395;A61K47/48;A61K48/00;A61K51/00;A61P9/10;A61P29/00;A61P31/04;A61P35/00;C07H21/04;C07K;C07K14/47;C07K14/515;C07K14/705;C07K16/28;C07K19/00;C12N;C12N5/06;C12N5/10;C12N15/00;C12N15/02;C12N15/09;C12N15/12;C12N15/19;C12N15/62;C12N15/63;C12P21/02;C12P21/08;C12R1/91;G01N33/53 |
主分类号 |
G01N33/50 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
